-
Kohli, Venkatesh dazzle as Bengaluru qualify for IPL play-offs
-
Probes ongoing into alleged abuse at 84 Paris preschools: prosecutor
-
Di Giannantonio wins Catalan MotoGP Grand Prix, Alex Marquez injured in horror crash
-
Fernandes equals assist record as Man Utd edge Forest thriller
-
Earps to leave PSG, in talks with London City Lionesses
-
Bowlers, Joy put Bangladesh on top in second Pakistan Test
-
Alex Marquez injured in horrific Catalan MotoGP crash
-
'Message for friends and foes': Libyan National Army conducts grand exercises
-
Bayern's Neuer sidelined again with leg issue
-
Adam Driver shuts down question about clashes with Lena Dunham
-
British soprano Felicity Lott dies aged 79
-
Roma near Champions League return with derby triumph, Napoli secure top four
-
Denmark's Antonsen wins badminton Thailand Open title
-
'Toxic' males Trump, Putin, Netanyahu to blame for wars, says star Bardem
-
Iran have 'constructive' meeting with FIFA over World Cup preparations
-
'Peaky Blinders' creator says he has licence to reinvent James Bond
-
Xabi Alonso appointed Chelsea manager on four-year deal
-
Mass Ukraine drone barrage kills 4 in Russia: Moscow
-
Gucci takes over New York's Times Square for fashion show
-
Lyles says 'well worth the journey' after winning 100m in Tokyo
-
Nepali duo break own records on Everest
-
North Korean women footballers land in South ahead of rare match
-
North Korean women footballers arrive in South Korea: AFP
-
Rousey demolishes Carano in MMA comeback fight
-
German 'chemical town' fears impact of industrial decline
-
Qantas flight diverted after man bites flight attendant
-
India scrambles to steady rupee as oil shock bites
-
McGregor to make UFC return with Holloway rematch
-
WHO declares international emergency as Ebola outbreak kills more than 80 in DR Congo
-
Crackdown in Southeast Asia pushes scam networks to Sri Lanka
-
'Geek' hangout to tourist draw: Japan's maid cafes
-
Spacecraft to probe how Earth fends off raging solar winds
-
Bulgaria's 'Bangaranga' wins Eurovision, with Israel second
-
Musk wants SpaceX to go public. Here's how it works
-
Big risks and rewards in upcoming IPOs at SpaceX, OpenAI, Anthropic
-
Pal in last duo could ease nerves for PGA leader Smalley
-
Ronaldo suffers more agony as Al Nassr lose 1-0 in AFC final
-
Venezuela expels Maduro ally Alex Saab to US again
-
Rising star Woad in charge at LPGA Queen City Championship
-
Rodgers returning with Steelers for 22nd season
-
Rahm on PGA: 'It's a battle out there'
-
Dara: dancing to victory at Eurovision
-
Penny Stock Enthusiasts, The Momentum Continues: As U.S. Markets Rally to Historic All-Time Highs - Higher Than the Dot-Com Boom Era - ELEKTROS Inc. Celebrates a Strong Friday Closing Surge of 33.33% While Continuing to Aggressively Advance Its Lithium Mining and EV Patent Technology
-
As U.S. Markets Continue Soaring to Historic All-Time Highs Reminiscent of the Dot-Com Boom Era, ELEKTROS Inc. Celebrates a Powerful 33.33% Friday Surge While Advancing Its Vision in Lithium Mining, EV Infrastructure, and Next-Generation Electrification Technologies
-
SMX and the New Age of Parity: When Certified Recycling Becomes Economic Infrastructure
-
As U.S. Markets Continue Surging to Historic All-Time Highs, ELEKTROS Believes This Could Be a Defining Opportunity for Penny Stock Investors Seeking Exposure to the Future of Lithium Mining, EV Infrastructure, and Next-Generation Electrification Technologies
-
Napoleon Solo wins 151st Preakness Stakes
-
Last 10 Eurovision winners
-
Smalley grabs PGA lead as wild final day showdown looms
-
Canada cruise passenger 'presumptive positive' for hantavirus
US approves updated Pfizer, Moderna shots targeting Omicron
US health officials on Wednesday authorized updated Covid-19 vaccinations by Moderna and Pfizer-BioNTech that specifically target the latest strains of the Omicron variant, with the goal of jump-starting a new booster campaign.
The two updated booster shots aimed at providing "better protection against Covid-19 caused by the Omicron variant" are approved for people age 12 and above for the Pfizer shot and 18 and older for Moderna, the Food and Drug Administration (FDA) said in a statement.
This new generation of anti-Covid vaccines targets both the original strain of coronavirus and the BA.4 and BA.5 lineages, the subvariants of Omicron that are causing the most cases in the United States and which the FDA predicts will circulate in the coming months.
Earlier this summer the US health department announced it had purchased 105 million doses from Pfizer and 66 million from Moderna for use over the fall and winter.
The vaccines have yet to be recommended by the Centers for Disease Control and Prevention, the nation's health protection agency. But an independent panel of experts is scheduled to be convened by the CDC on Thursday to discuss the updates.
CDC director Rochelle Walensky will be in charge of giving the final green light.
The new versions of the vaccines could potentially be available in the United States as early as next week.
"Receiving a booster that specifically targets the Omicron BA.4/.5 variant, currently the most prevalent strain of SARS-CoV-2, is an important public health measure that people can take to help protect themselves, especially as we head into a season filled with indoor gatherings," Moderna chief executive Stephane Bancel said in a statement.
The vaccines currently in circulation target the initial strain of the virus that first appeared in Wuhan, China. But they have gradually proven to be less effective against the variants that have appeared over time, due to rapid evolution of the virus.
In contrast to the Alpha and Delta variants, which eventually waned, Omicron and its subvariants have come to dominate infections worldwide in 2022.
Pfizer and Moderna have also filed for approval of their updated vaccines with the European Medicines Agency.
T.Ward--AMWN